Spots Global Cancer Trial Database for A Study of ZEN003694 in Patients With Metastatic Castration-Resistant Prostate Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of ZEN003694 in Patients With Metastatic Castration-Resistant Prostate Cancer
Official Title: A Phase 1 Safety and Tolerability Study of ZEN003694 in Patients With Metastatic Castration-Resistant Prostate Cancer
Study ID: NCT02705469
Interventions
Study Description
Brief Summary: This is an open label, Phase 1, dose escalation and dose confirmation study of ZEN003694 in patients with mCRPC.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
University of California Los Angeles Medical Center, Los Angeles, California, United States
University of California San Francisco Medical Center, San Francisco, California, United States
Karmanos Cancer Institute, Detroit, Michigan, United States
Karmanos Cancer Institute, Farmington Hills, Michigan, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Oregon Health & Science University, Portland, Oregon, United States
Virginia Oncology Associates, Hampton, Virginia, United States
Virginia Oncology Associates, Norfolk, Virginia, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
